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Abstract
Single nucleotide polymorphisms and pre- and peri-conception folic acid
(FA) supplementation and dietary data were used to identify one-carbon metabolic
factors associated with pregnancy outcomes in 3196 nulliparous women. In 325 partici-
pants, we also measured circulating folate, vitamin B12 and homocysteine. Pregnancy
outcomes included preeclampsia (PE), gestational hypertension (GHT), small for gesta-
tional age (SGA), spontaneous preterm birth (sPTB) and gestational diabetes mellitus
(GDM). Study findings show that maternal genotype MTHFR A1298C(CC) was associ-
ated with increased risk for PE, whereas TCN2 C766G(GG) had a reduced risk for sPTB.
Paternal MTHFR A1298C(CC) and MTHFD1 G1958A(AA) genotypes were associated
with reduced risk for sPTB, whereas MTHFR C677T(CT) genotype had an increased
risk for GHT. FA supplementation was associated with higher serum folate and vitamin
B12 concentrations, reduced uterine artery resistance index and increased birth
weight. Women who supplemented with <800 μg daily FA at 15-week gestation had a
higher incidence of PE (10.3%) compared with women who did not supplement (6.1%)
or who supplemented with ≥800 μg (5.4%) (P < .0001). Higher serum folate levels
were found in women who later developed GDM compared with women with uncom-
plicated pregnancies (Mean ± SD: 37.6 ± 8 nmol L−1 vs. 31.9 ± 11.2, P = .007). Fast
food consumption was associated with increased risk for developing GDM, whereas
low consumption of green leafy vegetables and fruit were independent risk factors for
SGA and GDM and sPTB and SGA, respectively. In conclusion, maternal and paternal
genotypes, together with maternal circulating folate and homocysteine concentrations,
and pre- and early-pregnancy dietary factors, are independent risk factors for
pregnancy complications.
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1 | INTRODUCTION
Adverse pregnancy outcomes, such as preeclampsia (PE), gestational
hypertension (GHT), infants born small for gestational age (SGA),
spontaneous preterm birth (sPTB) and gestational diabetes mellitus
(GDM), can affect up to one in two pregnancies and have multifacto-
rial aetiology and substantial maternal and neonatal morbidities
(Roberts, 2010; SA Health Pregnancy Outcome Unit, 2017). Multiple
factors can affect pregnancy health, including maternal nutrition,
age, lifestyle and socio-economic status, as well as maternal and
paternal genetics. Importantly, these factors often act in concert with
one another.
The maternal diet and nutritional stores provide nutrients for the
developing embryo and fetus. These nutrients underpin growth by
supporting high rates of DNA replication and cellular proliferation that
take place during fetal life (Maloney & Rees, 2005) and preventing
oxidative stress and inflammation, which have been associated with
aberrant placentation and pregnancy complications (Bhupathiraju &
Tucker, 2011; de Jonge et al., 2011; Field, van Aerde, Drager, Goruk, &
Basu, 2006; Furness, Dekker, & Roberts, 2011; Potdar et al., 2009;
Redman & Sargent, 2010; Sorokin et al., 2010). Folate (vitamin B9) is a
dietary micronutrient, found in a variety of green leafy vegetables and
fruits, which is required during pregnancy to support cell growth and
healthy placental development and function. Folate serves as a donor
of one-carbon units for the remethylation of homocysteine (Hcy) to
methionine and then to S-adenosylmethionine (SAM), the universal
methyl donor that affects systemic gene expression and cellular meth-
ylation potential (Bailey et al., 2015; Furness, Fenech, Khong,
Romero, & Dekker, 2008; Hague, 2003) (Figure 1). Folate, together
with vitamins B12 and B6 as cofactors, is required to maintain Hcy
levels within a normal range (Brouwer et al., 1999; Holt et al., 2009;
van Bussel et al., 2011), because at high concentrations, Hcy is pro-
inflammatory, leads to oxidative stress and has been associated with
an increased risk for pregnancy complications (Dekker et al., 1995;
Eskes, 2000; Forges et al., 2007; Poddar, Sivasubramanian, DiBello,
Robinson, & Jacobsen, 2001; Singh, Thomas, Owens, Hague, &
Fenech, 2015; Vollset et al., 2000).
When dietary folate consumption is inadequate, folic acid
(FA) supplementation becomes an important determinant of circulat-
ing Hcy, with daily FA doses ranging between 200 μg and 5 mg
being associated with 13–25% reduction in plasma Hcy levels
(Homocysteine Lowering Trialists Collaboration, 2005). In fact, FA
supplementation is recommended from 1 month prior to conception
F IGURE 1 The one-carbon metabolic pathway. Folate, as 5-methyl-THF, serves as the substrate for metabolic transformation of
homocysteine to methionine via MTR. Methionine is converted to S-adenosylmethionine (SAM), which serves as the principal methyl donor for
methylation. Vitamin B12 acts as an intermediate methyl carrier during the MTR-catalysed re-methylation of Hcy to methionine, cycling between
two states, cobalamin (I) and methylcobalamin (III) viaTCN II. Cobalamin (I) is a strong reductant that can be oxidised to produce inactive
cobalamin (II), which undergoes reductive methylation to methylcobalamin (III) via the MTRR enzyme using SAM as the methyl donor. Choline
derived betaine can also serve as a methyl donor for the conversion of Hcy to methionine. B6, vitamin B6; B12, vitamin B12 (cobalamin, in
various oxidative forms); CH3, methyl group; DHF, Dihydrofolate; Hcy, homocysteine; MTHFR, methylenetetrahydrofolate reductase; MTR,
methionine synthase;MTRR, methionine synthase reductase; SAM, S-Adenosylmethionine; SAH, S-adenosylhomocysteine; TCN II,
Transcobalamin II; THF, tetrahydrofolate. Modified after Furness et al. (2008)
Key messages
• Both parental genotypes in one-carbon metabolic path-
way genes influence pregnancy outcomes.
• Low consumption of green leafy vegetables and fruit
increases risk for several pregnancy complications,
whereas fast food consumption increases risk for gesta-
tional diabetes mellitus.
• Higher circulating folate levels increase risk for gesta-
tional hypertension and may be associated with gesta-
tional diabetes.
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and during the first trimester of pregnancy to reduce the risk for
neural tube defects; at least 400-μg daily dose is recommended in
Australia despite the 2009 mandatory fortification of FA in flour for
bread production (The Royal Australian and New Zealand College of
Obstetricians and Gynaecologists, 2014).
Folate and vitamin B status are not the only limiting factors for
Hcy remethylation in the one-carbon metabolic pathway. Polymor-
phisms in genes encoding enzymes involved in this pathway can
also affect the conversion of Hcy to methionine, leading to
increased circulating and cellular Hcy concentrations and DNA damage
(Botto et al., 2003; Fenech & Ferguson, 2001) and possible adverse
pregnancy outcomes (Furness et al., 2008; Laanpere et al., 2010;
Nair, Khanna, Singh, & Singh, 2013; Tiwari et al., 2015). For
example, methylenetetrahydrofolate reductase (MTHFR) converts 5,10-
methylenetetrahydrofolate to 5-methyltetrahydrofolate, the biologically
active form of folate that acts as a methyl donor for re-methylation of
Hcy to methionine. Single nucleotide substitutions inMTHFR are known
to affect enzyme function thus limiting the bioavailability of folate and
have been associated with pregnancy complications such as PE and
intrauterine growth restriction (IUGR) (Chedraui et al., 2015; Lachmeijer
et al., 2001; Liew & Gupta, 2015).
Our previous research has shown that genetic (Furness et al., 2008)
and nutritional (Furness et al., 2013) one-carbon metabolic factors at
20-week gestation are associated with adverse pregnancy outcomes in
a high-risk pregnancy cohort. In the current study, we investigated the
association between genetic, biochemical and nutritional one-carbon
metabolic factors at 15 ± 1 weeks of gestation with pregnancy compli-
cations in a low-risk nulliparous cohort.
2 | METHODS
2.1 | Study design
The Screening for Pregnancy Endpoints (SCOPE) study was an
international prospective cohort that recruited 5,628 nulliparous
pregnant women from Adelaide (Australia), Auckland (New Zealand),
Cork (Ireland), Leeds (United Kingdom), London (United Kingdom) and
Manchester (United Kingdom). The aim of SCOPE was to develop
screening tests to predict risk for pregnancy complications before
women become symptomatic. A total of 3,196 women were recruited
by the Adelaide–Auckland SCOPE centres between 2004 and 2008.
We used data generated from the Adelaide–Auckland cohort
(n = 3,196) to investigate associations between SNPs in the one-
carbon metabolic pathway, as well as preconception and early
pregnancy maternal diets, with pregnancy outcome in women who
developed a particular pregnancy complication compared with the
remaining cohort. Study cohort included cases of PE (n = 222), GHT
(n = 188), SGA (n = 298), sPTB (n = 156), GDM (n = 104) and other
pregnancy outcomes (n = 354) that were not all mutually exclusive.
There were 1,974 cases of uncomplicated pregnancies of which
209 were not tested for GDM and thus have an unknown outcome.
Cases with any unknown outcome were excluded from data analyses.
The results from this study are presented under study Part 1 in
Section 3.
Serum biochemistry was analysed in a subset of 325 women from
the Adelaide SCOPE cohort, for whom relevant blood biochemistry
data were available. The aim was to determine whether circulating
folate, vitamin B12 or Hcy, key players in the one-carbon metabolic
pathway, are associated with any of the variables or pregnancy out-
comes tested in the 3,196 cohort. As this is a nested case–control
study, which also includes cases of PE (n = 48), GHT (n = 46), SGA
(n = 44), sPTB (n = 43) and GDM (n = 33) selected at random with
111 uncomplicated pregnancies selected as controls, the findings will
be representative of the entire study population. All outcomes in the
nested case–control study were mutually exclusive and are presented
under study Part 2 in Section 3.
2.2 | Recruitment and inclusion/exclusion criteria
Nulliparous women with singleton pregnancies attending antenatal
clinics at the Adelaide, South Australia and Auckland, New Zealand
SCOPE centres between November 2004 and September 2008, at
15 ± 1 weeks of gestation, were recruited and provided written
informed consent. Women at high risk for pregnancy complications
because of underlying medical, gynaecological history, three or more
miscarriages or terminations of pregnancy were not eligible. Partners
were invited to participate and provided written informed consent.
Participants were excluded after recruitment due to pregnancy loss,
protocol violation or loss to follow-up.
2.3 | Data collection
Participants were interviewed and examined by research midwives at
15 ± 1 and 20 ± 1 weeks of gestation. Data collection included demo-
graphic information with socio-economic index (SEI) classified using
New Zealand criteria (scale of 10–90 with 10 representing the lowest
SEI) (SNZ, 2003), medical history, obstetric and family history, nutrient
supplementation, diet, smoking, alcohol and the use of recreational
drugs. Supplementation was recorded as total daily dose of FA. FA
supplementation dose was calculated from the strength and quantity
of tablets consumed and included both discrete FA tablets and FA
contained in multivitamin preparations. Supplementation dose of
800-μg daily FA was used as a reference dose because in Australia,
Elevit (Bayer) is the most popular brand of FA supplementation
containing 800 μg of FA. Maternal height, weight and blood pressure
were obtained at 15 ± 1 weeks of gestation. Umbilical and uterine
artery Doppler studies were performed at 20-week gestation by an
experienced sonographer as previously described (Groom et al., 2009)
and data used to calculate the umbilical and uterine artery resistance
indices (RI). Abnormal umbilical and uterine artery indices were
defined as >90th centile. All women were followed prospectively, and
pregnancy outcome data and infant measurements were recorded
within 72 h of birth.
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2.4 | Sample collection
Peripheral blood samples were collected, placed immediately on ice,
processed and stored at −80C within 3 h. DNA was extracted from
buffy coats from EDTA peripheral blood samples (QIAamp 96 DNA
blood kit, QIAGEN, USA) collected from all women and most
partners. Saliva samples were collected from partners who were
unwilling to undergo venipuncture, using Oragene kits (DNA
Genotek Inc., USA).
2.5 | Genotyping
Genotyping data were available for 2,842 (89%) of the 3,196
women. Genotyping for MTHFR C677T rs1801133, MTHFR A1298C
rs1801131, MTHFD1 G1958A rs2236225, MTR A2756G rs1805087,
MTRR A66G rs1801394 and TCN2 C766G rs1801198 single
nucleotide polymorphisms (SNPs) was performed at the Australian
Genome Research Facility (Brisbane) using the Sequenom
MassARRAY system (Agena Bioscience, USA). For quality control,
each sample was also genotyped for amelogenin to ensure that the
sex of the sample was correct (Sullivan, Mannucci, Kimpton, &
Gill, 1993). Chi-squared test was used to test genotypes for
Hardy–Weinberg Equilibrium.
2.6 | Dietary intake
Aspects of maternal preconception (1 month prior to becoming
pregnant) and early pregnancy (up until the first antenatal visit)
dietary intake were recorded by the research midwife at 15 ± 1 weeks
of gestation. Fast food consumption was defined as the combined
number of serves of burgers, fried chicken, pizza and fried hot chips
per week and was categorised as low (≤2 serves per week),
moderate (>2 and ≤4 serves per week) and high (>4 serves per
week) (Grieger et al., 2018). Fruit and green leafy vegetable
consumption was categorised as low (<1 serve per day) or moderate
(1 or more serves per day). Green leafy vegetables category
included all brassicas.
2.7 | Biochemical measurements
Complete biochemistry data were only available for 325 (10%)
women from the Adelaide SCOPE cohort. Plasma and serum
sampled at 15 ± 1 weeks of gestation were used to measure
circulating folate (nmol L−1), vitamin B12 (pmol L−1) and Hcy
(μmol L−1). Serum folate and vitamin B12 were quantified using the
ARCHITECT® folate and B12 assays (Abbott Laboratories, Abbott
Park, IL, USA). Total L-Hcy in plasma was quantified using the
AxSYM® homocysteine assay (Abbott, Wiedbaden, Germany).
Quantification was performed by the Division of Clinical Biochemistry
and Immunology, SA Pathology, Adelaide.
2.8 | Definitions of pregnancy outcomes
GHT was defined as blood pressure ≥140/90 mmHg arising after
20-week gestation without any other feature of the multisystem
disorder PE that resolves within 3-month postpartum (Brown
et al., 2000). PE was defined as GHT with proteinuria (24-h urinary
protein level of >300 mg or a spot urine protein: creatinine ratio of
≥30 mg mmol−1 creatinine or urine dipstick protein level ≥ ++) or any
multisystem complication of PE, including fetal growth restriction
(WHO recommendations, 2018). SGA was defined as birth weight
below the 10th customised centile adjusted for maternal height,
weight, parity, ethnicity, gestational age at delivery and infant sex
(McCowan, Stewart, Francis, & Gardosi, 2004). sPTB was spontaneous
preterm labour or preterm premature rupture of the membranes
resulting in birth at <37-week gestation. GDM was defined as glucose
intolerance that arises during pregnancy and is diagnosed around
26-week gestation by glucose challenge test using the new
(2016) World Health Organisation classification (fasting glucose of
≥5.1 mmol L−1 or following an Oral GlucoseToleranceTest, a 2-h level
of ≥8.5 mmol L−1). Uncomplicated pregnancy was defined as a
pregnancy in which no antenatal medical or obstetric complication
had been diagnosed, resulting in delivery of an appropriately grown,
healthy baby at ≥37 weeks of gestation.
2.9 | Statistics
All data analyses were performed using R version 3.5.3. Results were
reported as number and percent (n [%]) or mean ± standard deviation
(SD) where appropriate. Multivariable logistic regression was used to
determine the odds (with corresponding 95% confidence intervals) of
known SNPs in genes involved in the one-carbon metabolic pathway
for all five pregnancy complications, PE, GHT, SGA, sPTB and GDM,
adjusted for maternal age, body mass index (BMI), smoking status
and study centre. The relationships between SNPs and folate, vitamin
B12 and Hcy were also examined using linear regression, with mater-
nal age, BMI, smoking status and FA supplementation at 15 ± 1 weeks
of gestation as covariates. Descriptive statistics were reported
for maternal age, SEI, BMI and smoking status according to FA
supplementation status at 15-week gestation and for blood biochem-
istry measures (folate, vitamin B12 and Hcy) within the Adelaide
325 cohort where data were available. The association between FA
supplementation and neonatal outcomes was further examined using
linear regression adjusted for maternal age, BMI, smoking status and
study centre. Further analysis on folate, vitamin B12 and Hcy,
available within the Adelaide 325 cohort, was performed using linear
and logistic regression to examine their relationship with pregnancy
outcomes, adjusting for maternal age, BMI and smoking status. Blood
biochemistry results, including the effects of folate:vitaminB12 ratio,
on pregnancy outcomes were presented as odds ratios (95% CI). For
testing an effect (RR) of 1.5 with a sample size of 325, assuming a
standard deviation of 10 (SD of serum folate from 325 data), the
power is 77.8%.
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To examine the association between dietary intake
(at preconception and 15-week gestation) and pregnancy outcomes,
logistic regression was performed adjusting for maternal age, BMI,
smoking status, FA supplementation and study centre. Odds ratios
(95% CI) were reported. Similarly, linear regression was performed for
continuous neonatal outcomes and maternal blood biochemistry.
P < .05 was considered statistically significant.
2.10 | Ethical considerations
Ethical approval was obtained in Adelaide from the Central Northern
Adelaide Health Service Human Research Ethics Committee
(REC 1712/5/2008) and in Auckland by the Northern Region Ethics
Committee (AKX/02/00/364). The SCOPE study was registered
with the Australian New Zealand Clinical Trial Registry
(ACTRN12607000551493).
3 | RESULTS
3.1 | Adelaide and Auckland SCOPE 3196 cohort
3.1.1 | Baseline characteristics
The baseline characteristics data for SCOPE women included in this
study are summarised inTable 1. The mean age of women in the study
was 28 years. Women who developed PE were younger, had lower
SEI, higher BMI and mean arterial blood pressure (MAP) at 15-week
gestation and gave birth to babies of lower birth weight and gesta-
tional age compared with women without PE. Women who developed
GHT also had lower SEI and higher BMI and MAP at 15-week gesta-
tion compared with women without GHT; however, these women
gave birth to babies of higher birth weight. Women who delivered a
SGA baby had higher MAP at 15-week gestation, and their babies
were of lower birth weight and gestational age compared with non-
SGA cases. Women who developed GDM had a higher BMI and MAP
at 15 ± 1 weeks of gestation and, as per clinical management strategy,
gave birth to babies of lower gestational age compared with women
without GDM.
There was no association between smoking at 15-week gestation
and PE, GHT or GDM. However, more women with SGA and sPTB
smoked cigarettes at 15 ± 1 weeks of gestation (SGA 20.1% vs.
non-SGA 10.1%; P < .0001 and sPTB 19.9% vs. non-sPTB10.7%;
P = .001) (Table 1).
3.1.2 | Maternal and paternal SNPs and pregnancy
outcomes
The maternal genotype rs1801131 MTHFR A1298C (CC) was associ-
ated with increased risk for PE (OR 1.80, 1.13–2.88) when compared
with the AA genotype, whereas rs1801198 TCN2 C677G (GG) was
associated with a decreased risk for sPTB (OR 0.60, 0.36–0.99) when
compared with CC genotype (Table S1). The paternal genotypes
rs1801131 MTHFR A1298C (CC) and rs2236225 MTHFD1 G1958A
(AA) were associated with a decreased risk for sPTB (OR 0.32,
0.12–0.89 and OR 0.52, 0.28–0.99, respectively), whereas the pater-
nal MTHFR C677T (CT) genotype was associated with an increased
risk for GHT (OR 1.60, 1.08–2.39). Testing for compound heterozy-
gous MTHFR (C677T and A1298C) revealed no further associations
with any of the pregnancy outcomes measured.
3.1.3 | FA supplementation
Approximately 55% of the Adelaide and Auckland SCOPE women
included in this study took supplements containing FA preconception,
which increased to 75% of women at 15 ± 1 weeks of gestation.
Women who supplemented with <800-μg daily FA at 15 ± 1 weeks of
gestation were younger (26.2 ± 5.9 years vs. 27.1 ± 6.3 years;
mean ± SD) and had lower SEI (34.7 ± 15.4 vs. 40.0 ± 16.4; mean ± SD)
compared with women who did not use FA supplementation. Con-
versely, women who supplemented with ≥800-μg FA at 15 ± 1 weeks
of gestation were older (29.6 ± 5.1 years vs. 27.1 ± 6.3 years;
mean ± SD) and had higher SEI (44.9 ± 15.9 vs. 40.0 ± 16.4;
mean ± SD) compared with women who did not supplement
(Table 2A).
The percentage of women who smoked at 15 ± 1 weeks of gesta-
tion did not differ amongst those who supplemented with <800-μg
daily FA at 15 ± 1 weeks of gestation and those who did not supple-
ment (16.6% vs. 14.8%, P = .51). However, fewer women who sup-
plemented with ≥800-μg daily FA at 15 ± 1 weeks of gestation
smoked in early pregnancy or at 15 weeks of gestation compared with
those who did not supplement (8.6% vs. 11.2%, P = .008 and 5.5%
vs. 14.8%; P < .0001, respectively; Table 2A).
Womenwho supplemented with ≥800-μg FA daily at 15 ± 1 weeks
of gestation had lower uterine artery RI and gave birth to babies of
increased birth weight compared with women not supplementing
(Table 2A).
A total of 10.3% of women who supplemented with <800-μg
daily FA at 15-week gestation developed PE compared with 6.1% of
women who did not supplement (P = .0096). Supplementation with
≥800-μg daily FA at 15 ± 1 weeks of gestation was associated with a
lower rate of PE (5.4%) compared with supplementation with <800 μg
(10.3%; P = .0001; Table 2C).
3.1.4 | Maternal dietary intake and pregnancy health
and outcomes
Women who consumed 2–4 serves of fast food per week 1 month
prior to conception were more likely to develop GDM compared with
women who consumed less than 2 serves per week (OR 2.45; 95% CI
1.06–5.69; Table 3), and these effects were independent of BMI
and smoking.
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Women who consumed one or more serves of green vegetables
per day, 1 month prior to conception and at 15-week gestation, had
reduced odds of having a SGA baby compared with women who con-
sumed less than 1 serve of green vegetables per day (OR 0.73; 95%
CI 0.57–0.94 and OR 0.74; 95% CI 0.58–0.94, respectively; Table 3).
Green vegetables consumption prior to pregnancy was also associated
with a reduced risk of having GDM (OR 0.63; 95% CI 0.40–0.99), with
fewer women who developed GDM consuming one or more serves
of green vegetables per day compared with women without GDM
(35.6% vs. 48.8%).
Women who consumed one or more serves of fruit per day prior
to conception had reduced odds of SGA (OR of 0.75; 95%
CI 0.58–0.97) and sPTB (OR 0.66; 95% CI 0.46–0.95) (Table 3). Fruit
consumption at 15-week gestation was also associated with a reduced
odds of having sPTB (OR 0.65; 95% CI 0.44–0.96), with fewer women
with sPTB consuming one or more serves of fruit per day at 15 weeks
compared with women without sPTB (64% vs. 74.9%).
There was no association between maternal diet and gestational
age at delivery or between maternal diet and mean birth weight
when birth weight was adjusted for maternal age, BMI, smoking,
FA supplementation, study centre and gestational age (Table S2).
3.2 | Adelaide nested case–control 325 cohort study
3.2.1 | FA supplementation and blood biochemistry
In a subset of 325 women from the Adelaide SCOPE cohort for whom
blood biochemistry data were available, we assessed the relationship
between FA supplementation and circulating serum folate, serum vita-
min B12 and plasma Hcy levels at 15 ± 1 weeks of gestation. In this
subset, 30% of women supplemented with FA preconception, which
increased to 80% at 15 ± 1 weeks of gestation. Unsurprisingly,
women who supplemented with either <800- or ≥800-μg daily FA at
15 ± 1 weeks of gestation had increased circulating folate and vitamin
B12 levels compared with those who did not supplement. Mean circu-
lating folate concentration in women who did not supplement with
FA was 24.0 ± 10.3 nmol L−1 (mean ± SD), and it increased to
33.9 ± 9.1 nmol L−1 (in women who supplemented with <800-μg daily
FA; P < .0001) and 38.9 ± 6.8 nmol L−1 (in women who supplemented
with ≥800-μg daily FA; P < .0001). Mean circulating vitamin B12
concentration in women who did not supplement was
248.2 ± 76.5 pmol L−1 (mean ± SD), and it increased to
282.9 ± 101.8 pmol L−1 (in women who supplemented with <800-μg
daily FA; P = .023) and 289.5 ± 126.8 pmol L−1 (in women who
supplemented with ≥800-μg daily FA; P = .019). Women who
supplemented with ≥800-μg daily FA had lower Hcy levels
(6.1 ± 1.1 μmol L−1; mean ± SD) compared with those who did not
supplement (6.4 ± 1.4 μmol L−1); however, this difference was not
statistically significant (P = .074).
Hcy was however negatively correlated with serum folate
and vitamin B12 levels (r = −0.262, P < .001 and r = −0.283,
P < .001, respectively).
3.2.2 | Blood biochemistry in association with SNPs
and maternal lifestyle factors
A borderline increase in circulating Hcy levels was measured in
women with rs2236225 MTHFD1 GA and AA genotypes compared
with those with GG genotype (Hcymean ± SD: GG = 6.0 ± 1.3 μmol L−1;
GA = 6.4 ± 1.2 μmol L−1; AA=6.4±1.5 μmol L−1; P = 2.046), when data
were corrected for maternal age, BMI, smoking and FA supplementa-
tion. Although women with rs1801133 MTHFR C677T (TT) genotype
had increased circulating Hcy (mean ± SD: 6.5±1.1 μmol L−1) and
reduced serum folate (mean ± SD: 30.5±11.5 nmol L−1) compared
with those with CC genotype (mean ± SD: 6.2±1.2 μmol L−1 and 34.1
±10.5 nmol L−1, respectively), these differences were not statistically
significant (P = .219), possibly due to the small number of women with
the TT genotype (TT n = 38; CC n = 149). There was no association
between maternal MTR, MTRR and TCN2 genotypes and plasma Hcy
concentration. The outcomes were the same when data were
adjusted for folate and vitamin B12.
Hcy levels were higher in women who smoked at 15 ± 1 weeks of
gestation compared with nonsmokers (8.2% increase [95% CI
2.7–14.1%]; P = .003), whereas serum folate and vitamin B12 levels
were lower (28.2% decrease in folate [95% CI 20.3–35.3%];
P < .0001; and 10.5% decrease in vitamin B12 [95% CI 1.7–18.5%];
P = .021) in smokers compared with nonsmokers. Circulating folate,
vitamin B12 and Hcy levels were not associated with alcohol
consumption, but this could be a reflection of low number of women
who consumed alcohol (n = 13) compared with those who did not
(n = 312); mean folate, vitamin B12 and Hcy levels in nonconsumers
versus consumers of alcohol were 33.3 ± 10.1 vs. 32.3 ± 10.7 nmol L−1,
P = .734; 277.8 ± 105.2 vs. 268.2 ± 95.7 pmol L−1, P = .748; 6.2 ± 1.3
vs. 6.2 ± 1.4 μmol L−1, P = .858, respectively. Maternal age was associ-
ated with increased serum folate (1.015 [1.006–1.023]), whereas
maternal MAP and BMI were associated with lower serum vitamin
B12 (0.995 [0.990–0.999] and 0.990 [0.985–0.996], respectively),
presented as effects (95% CI), which are ratios of geometric means.
There was no association between fast food or fruit consumption
and blood biochemistry. However, women who, at 15-week gestation,
consumed one or more serves of green leafy vegetables per day had
higher circulating vitamin B12 levels than those who consumed less
than one serve per day (298.5 ± 14.7 vs. 271 ± 6 pmol L−1; P = .048).
This relationship was strengthened when corrected for maternal age,
BMI, smoking and FA supplementation (P = .037; Table S3).
3.2.3 | Blood biochemistry in association with
pregnancy outcomes
Serum folate levels were higher in women who developed GHT
(36.7 ± 7.1 nmol L−1) and GDM (37.6 ± 8 nmol L−1) compared with
those with uncomplicated pregnancies (31.9 ± 11.2 nmol L−1; P = .005
and P = .007, respectively), but the effect of serum folate on the risk
of developing GDM was lost after adjusting for potential confounders
(Table 4A).
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Serum vitamin B12 levels were not associated with any of the
five adverse pregnancy outcomes assessed.
Compared with women who had an uncomplicated pregnancy,
women who developed GHT had higher serum folate to vitamin B12
ratio at 15-week gestation (1.98; 95% CI: 1.13–3.47; P = .017).
While plasma Hcy at 15 ± 1 weeks of gestation was increased in
women who delivered an SGA baby compared with those with
uncomplicated pregnancies (6.6 ± 0.2 μmol L−1 compared with
6.1 ± 0.1 μmol L−1), the significance of the association was lost after
adjusting for potential confounders. Higher circulating Hcy levels
were positively associated with umbilical RI (1 μmol L−1 increase
is associated with a 0.006 increase in umbilical RI; 95% CI
0.001–0.0110) (Table 4B).
4 | DISCUSSION
Polymorphisms in genes involved in the one-carbon metabolic
pathway can alter enzyme activity and thus folate, vitamin B12 and
Hcy metabolism (Fredriksen et al., 2007; Ganz et al., 2016; Guinotte
et al., 2003). MTHFD1 plays an important role in the flux between
5,10-methylene THF and 10-formyl THF thereby influencing the
availability of 5-methyl THF for Hcy re-methylation (Horne, 2003).
MTHFD1 G1958A mutation has been shown to reduce the stability of
its synthetase domain, altering its metabolic activity to limit the avail-
ability of methyl THF (Christensen et al., 2009). It is therefore unsur-
prising that there were associations between the maternal GA and AA
genotype and higher circulating Hcy levels. Impaired MTHFD1
enzyme function has also been shown to affect purine synthesis and
pregnancy outcome, with the AA genotype being linked with
neural tube defects and cardiac malformations in humans (Christensen
et al., 2009; Parle-McDermott et al., 2006) and developmental defects
in animal models (Christensen et al., 2013). Paternal MTHFD1 G1958A
(AA) genotype on the other hand and MTHFR A1298C (CC) genotype
were both associated with reduced risk of sPTB. Previous studies
have shown that low folate is associated with increased risk for sPTB;
however, our results show that these two paternal genotypes that are
normally associated with low folate reduced the risk of sPTB. These
conflicting results may be due to the fact that the paternal genotype
did not impact on the maternal levels of folate, particularly consider-
ing that majority of women recruited were supplementing during early
pregnancy, which would override genetic influence.
We found a significant association between the maternal MTHFR
A1298C SNP and PE but surprisingly no association between the
maternal MTHFR C677T (TT) genotype and any of the pregnancy
outcomes. Paternal MTHFR C677T (CT) genotype was however
associated with GHT. This association is difficult to interpret for two
reasons. Firstly, the association is detected with the heterozygous
genotype, which has been shown to reduce MTHFR activity but not
to the same degree as the homozygous genotype (TT). If the associa-
tion is due to the impact on MTHFR activity, one would expect to also
see an association with the TT genotype. Secondly, it is currently
unknown if the paternal genotype can influence maternal blood
pressure levels; however, it is plausible that the fetal and
placental genotype could impact on maternal blood flow and blood
pressure, which is indirectly linked to the paternal genotype. Further-
more, McNulty et al. (2017) have shown that riboflavin, the cofactor
for MTHFR, may be associated with risk for blood pressure in associa-
tion with the MTHFR genotype (McNulty, Strain, Hughes, &
Ward, 2017). Future studies investigating MTHFR and hypertension
in pregnancy would benefit from measuring riboflavin levels and
investigating this gene–nutrient interaction. MTHFR is an enzyme
involved in the conversion of 5,10-methylenetetrahydrofolate to
5-methyltetrahydrofolate. The former is the form of folate found
mainly within cells, whereas the latter is the main form of circulating
folate found in blood (Pfeiffer et al., 2015) that is used for Hcy re-
methylation. Polymorphisms in both MTHFR A1298C (CC) and C677T
(TT) are reported to have decreased enzyme activity and are thus
associated with impaired production of 5-methyl THF (van der Put &
Blom, 2000), which would explain the associations between the
A1298C (CC) genotype and PE and sPTB but not the lack of associa-
tion between maternal C677T SNP and any of the pregnancy out-
comes, which could be due to only 9.8% of women having the
TT genotype. The low number of women with the TT genotype could
also explain the lack of statistical significance in the observed
decrease in circulating folate and increase in Hcy levels in women
with the C677T (TT) genotype. Others (Parle-McDermott et al., 2006;
van der Put & Blom, 2000) have previously suggested that the combi-
nation of the expression of two genotypes, MTHFR A1298C and
C677T, is important in terms of red cell folate levels and circulating
Hcy levels. However, further examination of the effects of a combina-
tion of MTHFR A1298C and C677T genotypes revealed no association
with neither circulating Hcy, folate nor vitamin B12, which once again
is likely due to low sample numbers in theTT genotype category.
We also found an association between the maternal TCN2 C776G
(GG) genotype and a decreased risk for sPTB. Transcobalamin
2 (TCN2) is a protein that is essential for binding circulating vitamin
B12 for its transport into cells (Oussalah, Levy, Filhine-Tresarrieu,
Namour, & Gueant, 2017). TCN2 polymorphism affects not only its
expression but ultimately its plasma concentration and thus the
availability of vitamin B12 to aid in re-methylation of Hcy (Oussalah
et al., 2017). The C > G substitution alters the structure of the TCN2
protein affecting its affinity for vitamin B12, resulting in easier release
from the bound TCN2 transporter (Afman, Lievers, van der Put,
Trijbels, & Blom, 2002; Joslin, Green, German, & Lange, 2014) and
thus reduced vitamin B12 transport into cells and ultimately higher
Hcy levels compared with the CC genotype. This association conflicts
with the findings from our study indicating the maternal TCN2 C776G
(GG) genotype is associated with reduced risk for sPTB. However,
because majority of women were taking a supplement containing
vitamin B12, it is likely their increased B vitamin intake has
outweighed the genetic influence on B12 levels. Furthermore, in this
study, we have shown that BMI and maternal MAP were significantly
associated with vitamin B12 levels.
Pre-existing hypertension was an exclusion criterion for SCOPE
recruitment (Andraweera et al., 2018). However, women who
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developed a pregnancy complication, with the exception of sPTB, had
higher MAP at 15-week gestation compared with the rest of the
cohort. We found that increased umbilical artery RI at 15-week
gestation, suggesting poor placental blood supply, was associated with
increased plasma Hcy. We also found that women who supplemented
with FA at 15-week gestation had reduced umbilical artery RI. As FA
supplementation was associated with increased serum folate levels,
these findings are consistent with evidence suggesting that high Hcy
and low folate levels may be early markers for women at risk of
poor placentation and subsequent pregnancy complications (Furness
et al., 2013). The negative correlation between Hcy and circulating
folate and vitamin B12, in the current study of low-risk nulliparous
women, is in agreement with what is currently known about Hcy and
pregnancy health from our previous work (Furness et al., 2013;
Furness, Yasin, Dekker, Thompson, & Roberts, 2012). However, we
found no direct association between low folate levels and some preg-
nancy complications. Limited availability of folate results in an
increased use of choline derived betaine as an alternative methyl
donor for the conversion of Hcy to methionine (Ganz et al., 2016),
which could explain the lack of association between serum folate
levels and pregnancy outcomes in our study.
Our observation of associations between serum folate levels and
GHT, as well as FA supplementation and PE, are unexpected.
Although the higher incidence of PE in women who supplemented
with <800-μg daily FA at 15-week gestation could reflect their lower
SEI status, further studies are needed to determine the association
between higher serum folate levels and GHT. Further studies are
warranted to confirm and determine the relevance of this, given the
recommended FA supplementation to reduce neural tube defects and
particularly in light of the mandatory FA fortification implemented
globally. It will be valuable to determine what effects mandatory
fortification of the food supply with FA, in Australia (Food Standards
Australia New Zealand, 2007) and in many countries globally, has on
pregnancy outcomes besides decreasing the incidence of neural tube
defects. A recent prospective cohort study from China reported an
association between FA supplementation during pregnancy and risk
for GDM (Zhu et al., 2016), which is in line with our observations on
increased serum folate levels in SCOPE women who developed GDM,
the latter observation warranting further investigation.
In addition to genetic and biochemical factors, this study also high-
lights the importance of maternal diet on pregnancy health and out-
come. This information is highly relevant for all women of childbearing
age particularly for those living with social and economic disadvantage,
as represented here by the subset of the Adelaide cohort, where the
intake of fruit and vegetables amongst young women was very low and
that of fast food was very high, with close to 50% of women reporting
that they consumed at least four serves of fast food each week.
We have shown that women who consumed 2–4 serves of fast
food per week prior to conception had an increased risk of developing
GDM compared with all other women in the cohort, which is in line
with reports by others (Dominguez et al., 2014; Lamyian et al., 2017).
Whereas our data did not show an association with fast food intake
and Hcy levels, most likely due to the small numbers in the ‘low’ fast
food intake category, others have shown an association between
high-fat diet and increased Hcy (Berstad et al., 2007). We have,
however, shown that increased consumption of green leafy vegeta-
bles in early pregnancy, as well as FA supplementation prior to con-
ception and during early pregnancy, associates with higher circulating
serum vitamin B12 and folate required to maintain Hcy levels. This
was expected and consistent with previous reports associating
folate/FA intake and increased circulating folate (Crider, Qi, Devine,
Tinker, & Berry, 2018; Looman et al., 2018; McNulty et al., 2013;
Wen et al., 2016) (Ostan et al., 2018). It should be noted that SCOPE
study recruitment occurred prior to mandatory fortification of the
food supply with FA in Australia, so it would be interesting to investi-
gate whether FA supplementation is still beneficial in increasing
circulating folate levels in pregnant women in the current post-
fortification population.
Increased fruit and/or green vegetable consumption, as shown in
this study, is also associated with reduced odds ratio for SGA
(McCowan et al., 2010), sPTB and GDM. Taken together, our findings
support a recommendation to increase consumption of green leafy
vegetables and fruit and limit consumption of fast food, from prior to
conception and in early pregnancy, in order to reduce the risks for
pregnancy complications. These recommendations are in agreement
with a recent report on preconception and perinatal diet and preg-
nancy outcome, which proposed that a Mediterranean diet comprising
high protein, green leafy vegetables and fruit, reduces the risk of
sPTB, whereas a high-fat/sugar fast food diet associates with sPTB
and shorter gestation (Chen et al., 2016).
A limitation of our study is the reliance on maternal recall for
patient-reported dietary consumption and a small sample size for the
nested case–control study. Strengths of the study include the robust
design and the collection of data using questionnaires administered at
face-to-face interviews. Furthermore, use of a real-time database with
strict data monitoring by research midwives reduced the likelihood of
data entry errors.
5 | CONCLUSION
In summary, the main findings in this study point to an association
between a combination of genetic and lifestyle factors, which reflect a
period of 1 month prior to conception and early in gestation, as
important parameters in determining maternal biochemistry and preg-
nancy health and outcome in a low-risk nulliparous cohort. This study
also highlights the importance of healthy dietary choices that include
minimal consumption of fast food in combination with increased
fruit and green leafy vegetable consumption prior to conception, for
minimising risk for pregnancy complications. At present, there are
limited studies on maternal fast food consumption, particularly prior
to conception, and pregnancy outcome. Further studies are needed to
assess the relevance of the association between maternal circulating
folate levels and GHT, and potentially GDM, particularly in light of the
global mandatory FA fortification programme implemented to reduce
the incidence of neural tube defects.
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